Liu Yin, Sharma Sambad, Watabe Kounosuke
2500 N. State, Jackson MS 39216, University of Mississippi Medical Center, Cancer Institute.
Pathology Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", via Mariano Semmola 80131, Napoli, Italy,
Front Biosci (Schol Ed). 2015 Jun 1;7(1):94-108. doi: 10.2741/S427.
Recent systematic genomic studies have revealed a broad spectrum of lncRNAs that are involved in a variety of disease (diseases), including tumor progression, by regulating gene expression at epigenetic, transcriptional and post-transcriptional levels. However, their exact roles of physiological function and the mechanism (mechanisms) of action are yet to be clarified. In breast cancer research, several lncRNAs are identified as tumor driving oncogenic lncRNAs and few are identified as tumor suppressive lncRNAs. They are involved in cell growth, apoptosis, cell migration and invasiveness as well as cancer cell stemness. Therefore, this new class of RNAs may serve as biomarkers for diagnostic and prognostic purpose and also as potential therapeutic targets. This review summarizes the current information about lncRNAs that are particularly involved in breast cancer progression and also discusses the potential translational application of these newly discovered nucleic acids.
最近的系统基因组学研究揭示了广泛的长链非编码RNA(lncRNA),它们通过在表观遗传、转录和转录后水平调节基因表达,参与包括肿瘤进展在内的多种疾病。然而,它们确切的生理功能作用及作用机制尚待阐明。在乳腺癌研究中,一些lncRNA被鉴定为驱动肿瘤的致癌lncRNA,而只有少数被鉴定为肿瘤抑制lncRNA。它们参与细胞生长、凋亡、细胞迁移和侵袭以及癌细胞干性。因此,这类新的RNA可能作为诊断和预后的生物标志物,也可能成为潜在的治疗靶点。本综述总结了目前关于特别参与乳腺癌进展的lncRNA的信息,并讨论了这些新发现核酸的潜在转化应用。